This study is evaluating a new artificial intelligence (AI) software called CaRi-Heart® Analysis. This software looks at images from your regular Coronary CT Angiography (CCTA) scan to measure inflammation in your heart arteries. The goal is to see if this extra information helps doctors make better decisions about your care for coronary artery disease (a condition where plaque builds up in the heart's arteries). You can join if you are between 18 and 80 years old, are having a CCTA for suspected or known coronary artery disease, and have not had bypass surgery. The study will be successful if doctors change their treatment plans more often after seeing the CaRi-Heart® results, helping to identify and manage heart disease earlier. This study is currently recruiting about 15,000 participants.

Study design

This is an interventional study involving about 15,000 participants. It aims to compare doctors' decisions before and after using the CaRi-Heart® Analysis.

What's involved

You would undergo a standard CCTA scan as part of your regular care. Your existing CCTA images would then be analyzed by the CaRi-Heart® software; no additional scans or procedures are needed from you.

Compensation

Not stated in the trial record.

Follow-up

Your clinical management decisions will be assessed for up to 60 days following your CCTA completion.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.